Advances in the Discovery of CC Chemokine Receptor 2 Antagonists

被引：20
|
作者：
Carter, Percy H. [1 ]
Cherney, Robert J. [1 ]
Mangion, Ian K. [1 ]
机构：
[1] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ 08543 USA
来源：
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42 | 2007年 / 42卷
关键词：
D O I：
10.1016/S0065-7743(07)42014-0
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：211 / 227
页数：17
相关论文
共 50 条
  • [31] Neolignans from the Arils of Myristica fragrans as Potent Antagonists of CC Chemokine Receptor 3
    Morikawa, Toshio
    Hachiman, Ikuko
    Matsuo, Kazuhiko
    Nishida, Eriko
    Ninomiya, Kiyofumi
    Hayakawa, Takao
    Yoshie, Osamu
    Muraoka, Osamu
    Nakayama, Takashi
    JOURNAL OF NATURAL PRODUCTS, 2016, 79 (08): : 2005 - 2013
  • [32] Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists
    Varnes, JG
    Gardner, DS
    Santella, JB
    Duncia, JV
    Estrella, M
    Watson, PS
    Clark, CM
    Ko, SS
    Welch, P
    Covington, M
    Stowell, N
    Wadman, E
    Davies, P
    Solomon, K
    Newton, RC
    Trainor, GL
    Decicco, CP
    Wacker, DA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (07) : 1645 - 1649
  • [33] Synthesis and evaluation of CC chemokine receptor-4 (CCR4) antagonists
    Newhouse, BJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U122 - U123
  • [34] The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b
    Martinelli, R
    Sabroe, I
    LaRosa, G
    Williams, TJ
    Pease, JE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (46) : 42957 - 42964
  • [35] Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3
    Hayes, Martin E.
    Wallace, Grier A.
    Grongsaard, Pintipa
    Bischoff, Agnieszka
    George, Dawn M.
    Miao, Wenyan
    McPherson, Michael J.
    Stoffel, Robert H.
    Green, David W.
    Roth, Gregory P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (05) : 1573 - 1576
  • [36] Discovery of potent and orally bioavailable N,N′-diarylurea antagonists for the CXCR2 chemokine receptor
    Jin, Q
    Nie, H
    McCleland, BW
    Widdowson, KL
    Palovich, MR
    Elliott, JD
    Goodman, RM
    Burman, M
    Sarau, HM
    Ward, KW
    Nord, M
    Orr, BM
    Gorycki, PD
    Busch-Petersen, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (17) : 4375 - 4378
  • [37] Discovery and Lead Optimization of a Novel Series of CC Chemokine Receptor 1 (CCR1)-Selective Piperidine Antagonists via Parallel Synthesis
    Cavallaro, Cullen L.
    Briceno, Stephanie
    Chen, Jing
    Cvijic, Mary Ellen
    Davies, Paul
    Hynes, John, Jr.
    Liu, Rui-Qin
    Mandlekar, Sandhya
    Rose, Anne V.
    Tebben, Andrew J.
    Van Kirk, Katy
    Watson, Andrew
    Wu, Hong
    Yang, Guchen
    Carter, Percy H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 9643 - 9653
  • [38] Discovery of an orally-bioavailable CC Chemokine Receptor 2 antagonist derived from an acyclic diaminoalcohol backbone
    Carter, Percy H.
    Brown, Gregory D.
    King, Sarah R.
    Voss, Matthew E.
    Tebben, Andrew J.
    Cherney, Robert J.
    Mandlekar, Sandhya
    Lo, Yvonne C.
    Yang, Gengjie
    Miller, Persymphonie B.
    Scherle, Peggy A.
    Zhao, Qihong
    Decicco, Carl P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (09) : 3311 - 3316
  • [39] Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists
    Miah, Afjal H.
    Champigny, Aurelie C.
    Graves, Rebecca H.
    Hodgson, Simon T.
    Percy, Jonathan M.
    Procopiou, Panayiotis A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (20) : 5327 - 5340
  • [40] Crystal Structure of CC Chemokine Receptor 2A in Complex with an Orthosteric Antagonist Provides Insights for the Design of Selective Antagonists
    Apel, Anna-Katharina
    Cheng, Robert K. Y.
    Tautermann, Christofer S.
    Brauchle, Michael
    Huang, Chia-Ying
    Pautsch, Alexander
    Hennig, Michael
    Nar, Herbert
    Schnapp, Gisela
    STRUCTURE, 2019, 27 (03) : 427 - +
12345